Goosehead Insurance Grants Pre-IPO Holders Veto Power Over Major Corporate Actions and Board Control

summarizeSummary

Goosehead Insurance's founding Pre-IPO Holders secured veto power over major corporate actions and the right to designate a majority of the board under a new stockholders agreement, significantly strengthening their control over the company.

check_boxKey Events · Corporate Governance and Compliance · GSHD

• Pre-IPO Holders Gain Veto Power

  The Amended and Restated Stockholders Agreement requires Pre-IPO Holder approval for M&A, equity issuances over $50M, charter/bylaw amendments, new lines of business, and board size changes, as long as they hold at least 10% of outstanding common stock.

• Board Nomination Rights Secured

  Pre-IPO Holders may designate nominees for a majority of the board, including the chairman, subject to a fiduciary override by the board.

• Executive Compensation Oversight

  Approval of the Pre-IPO Holders is required for compensation and benefits decisions relating to the CEO, CFO, COO, General Counsel, and Controller.

• Settlement of Dollens Litigation

  The agreement implements the terms of a 2023 settlement of the Dollens v. Goosehead Insurance lawsuit, which challenged the original stockholders agreement under the Moelis decision.

auto_awesomeAnalysis · GSHD · Finance

Effective July 8, 2026, an Amended and Restated Stockholders Agreement hands the founding Jones family and related entities—the Pre-IPO Holders—sweeping approval rights over M&A, large equity issuances, charter changes, and executive compensation, provided they collectively own at least 10% of the company. They also gain the right to designate a majority of the board, including the chairman. This cements insider control and could deter takeovers or dilutive capital raises without their consent. The board retains a fiduciary override, but in practice, the Pre-IPO Holders now hold a structural veto over major strategic moves.